Search
for
Sort by
Research 61–90 of 110
- Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial
- Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response
- Profile and Clinical Character of COVID-19 Patients at Zahirah Hospital, South Jakarta
- Profile and Clinical Character of COVID-19 Patients at Zahirah Hospital, South Jakarta
- The JAK/STAT signaling pathway: from bench to clinic
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
- Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
- Antiviral and Anti-Inflammatory Plant-Derived Bioactive Compounds and Their Potential Use in the Treatment of COVID-19-Related Pathologies
- Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight
- Induced pluripotent stem cells: Generation methods and a new perspective in COVID-19 research
- Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection
- Application of Baricitinib in Dermatology
- Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center
- Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors
- Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
- Two years of SARS-CoV-2 infection (2019–2021): structural biology, vaccination, and current global situation
- Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology
- Upper gastrointestinal bleeding during the COVID-19 pandemic; particularities of diagnosis and therapy
- The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- Characterization of Post-COVID-19 Clinical Manifestations Among Patients Visiting a Post-COVID-19 Clinic in a Tertiary Care Center: A Descriptive Study
- An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions